A combination meningitis vaccine (for some kids and adults) Pfizer’s new vaccine Penbraya, which was approved by the FDA in ...

Penbraya also combines elements from Pfizer’s meningococcal vaccines Trumenba and Nimenrix, which together made around $300 million in 2023, and started shipping in the US earlier this year.

The FDA approved Pfizer’s Penbraya for vaccinating against five bacterial groups that can cause meningococcal disease. Pfizer already has vaccines covering those groups, but Penbraya addresses ...

In November 2023, GlobalData reported significant changes in the meningococcal vaccine market with the launch of Pfizer's Penbraya. The CDC's Advisory Committee on Immunisation Practices ...

MenABCWY vaccine (Penbraya): This vaccine protects against serotypes A, B, C, W, and Y. Healthcare professionals may refer to this preparation as a pentavalent vaccine because it helps protect ...

Medscape Medical News, September 23, 2024 Alert EU OKs Meningococcal Disease Vaccine The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the ...

has also recommended administering Penbraya when both meningococcal groups A, C, W and Y (MenACWY) and meningococcal group B (MenB) vaccines are indicated at the same visit for healthy patients ...

WebMD Health News, September 23, 2024 Alert EU OKs Meningococcal Disease Vaccine The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the ...